AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2015
Feb 20, 2015
31046_dirs_2015-02-20_260ebe25-e749-4339-8a37-cb1d72712c2b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-02-17
Reporting Person: Almstead Neil Gregory (EVP, Research and CMC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-17 | Common Stock | M | 3592 | $10.85 | Acquired | 33473 | Direct |
| 2015-02-17 | Common Stock | M | 312 | $10.85 | Acquired | 33785 | Direct |
| 2015-02-17 | Common Stock | S | 1504 | $53.37 | Disposed | 32281 | Direct |
| 2015-02-17 | Common Stock | S | 2400 | $54.56 | Disposed | 29881 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-17 | Stock Option (Right To Buy) | $10.85 | M | 3592 | Acquired | 2023-05-15 | Common Stock (3592) | Direct |
| 2015-02-17 | Stock Option (Right To Buy) | $10.85 | M | 312 | Acquired | 2023-05-15 | Common Stock (312) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1374 | Indirect |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.10 to $54.05 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.18 to $54.70 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 30, 2014.
F5: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.